/Agilent%20Technologies%20Inc_%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
Valued at a market cap of $34.5 billion, Agilent Technologies, Inc. (A) is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. The Santa Clara, California-based company provides instruments, software, services, and consumables that help laboratories improve efficiency and accuracy in scientific research, quality control, and clinical applications. Operating in over 110 countries, Agilent maintains a strong global footprint, serving top research institutions and industrial sectors.
Companies valued at $10 billion or more are typically classified as “large-cap stocks,” and Agilent fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the diagnostics & research industry. The company excels in chromatography, mass spectrometry, and spectroscopy solutions, making it a key player in pharmaceutical research, biotechnology, and environmental testing. With a strong presence in life sciences and diagnostics, Agilent supports drug discovery, genetic research, and precision medicine through cutting-edge diagnostic tools.